1. Home
  2. NRXP vs NTIP Comparison

NRXP vs NTIP Comparison

Compare NRXP & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • NTIP
  • Stock Information
  • Founded
  • NRXP 2015
  • NTIP 1990
  • Country
  • NRXP United States
  • NTIP United States
  • Employees
  • NRXP N/A
  • NTIP N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • NTIP Multi-Sector Companies
  • Sector
  • NRXP Health Care
  • NTIP Miscellaneous
  • Exchange
  • NRXP Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • NRXP 32.6M
  • NTIP 28.6M
  • IPO Year
  • NRXP N/A
  • NTIP 1998
  • Fundamental
  • Price
  • NRXP $3.34
  • NTIP $1.25
  • Analyst Decision
  • NRXP Strong Buy
  • NTIP
  • Analyst Count
  • NRXP 4
  • NTIP 0
  • Target Price
  • NRXP $28.50
  • NTIP N/A
  • AVG Volume (30 Days)
  • NRXP 240.0K
  • NTIP 13.6K
  • Earning Date
  • NRXP 08-13-2025
  • NTIP 08-11-2025
  • Dividend Yield
  • NRXP N/A
  • NTIP 8.33%
  • EPS Growth
  • NRXP N/A
  • NTIP N/A
  • EPS
  • NRXP N/A
  • NTIP N/A
  • Revenue
  • NRXP N/A
  • NTIP $250,000.00
  • Revenue This Year
  • NRXP N/A
  • NTIP N/A
  • Revenue Next Year
  • NRXP N/A
  • NTIP N/A
  • P/E Ratio
  • NRXP N/A
  • NTIP N/A
  • Revenue Growth
  • NRXP N/A
  • NTIP N/A
  • 52 Week Low
  • NRXP $1.10
  • NTIP $1.16
  • 52 Week High
  • NRXP $6.01
  • NTIP $1.78
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 60.08
  • NTIP 49.11
  • Support Level
  • NRXP $2.90
  • NTIP $1.20
  • Resistance Level
  • NRXP $3.53
  • NTIP $1.30
  • Average True Range (ATR)
  • NRXP 0.19
  • NTIP 0.05
  • MACD
  • NRXP -0.03
  • NTIP -0.00
  • Stochastic Oscillator
  • NRXP 84.13
  • NTIP 49.29

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: